A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
Status:
Completed
Trial end date:
2017-08-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if Symbicort® (budesonide/formoterol) Turbuhaler® is
effective in treating asthma when used 'as needed' in patients with milder asthma. The
efficacy of Symbicort® 'as needed' will be compared with: 1) terbutaline Turbuhaler® 'as
needed' and with 2) Pulmicort (budesonide) Turbuhaler® twice daily plus terbutaline
Turbuhaler® 'as needed'.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Terbutaline